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Mitotic catenation is monitored and resolved
by a PKCe-regulated pathway
Nicola Brownlow1, Tanya Pike1, Daniel Zicha2, Lucy Collinson3 & Peter J. Parker1,4
Exit from mitosis is controlled by silencing of the spindle assembly checkpoint (SAC). It is
important that preceding exit, all sister chromatid pairs are correctly bioriented, and that
residual catenation is resolved, permitting complete sister chromatid separation in the
ensuing anaphase. Here we determine that the metaphase response to catenation in mam-
malian cells operates through PKCe. The PKCe-controlled pathway regulates exit from the
SAC only when mitotic cells are challenged by retained catenation and this delayed exit is
characterized by BubR1-high and Mad2-low kinetochores. In addition, we show that this
pathway is necessary to facilitate resolution of retained catenanes in mitosis. When delayed
by catenation in mitosis, inhibition of PKCe results in premature entry into anaphase with
PICH-positive strands and chromosome bridging. These findings demonstrate the importance
of PKCe-mediated regulation in protection from loss of chromosome integrity in cells failing to
resolve catenation in G2.
DOI: 10.1038/ncomms6685 OPEN
1 Protein Phosphorylation Laboratory, Cancer Research UK London Research Institute, 44 Lincolns Inn Fields, London WC2A 3LY, UK. 2 Light Microscopy,
Cancer Research UK London Research Institute, London, WC2A 3LY, UK. 3 Electron Microscopy, Cancer Research UK London Research Institute, London
WC2A 3LY, UK. 4 Division of Cancer Studies, King’s College London, New Hunt’s House, Guy’s Campus, London SE1 1UL, UK. Correspondence and requests
for materials should be addressed to P.J.P. (email: peter.parker@cancer.org.uk).
NATURE COMMUNICATIONS | 5:5685 | DOI: 10.1038/ncomms6685 | www.nature.com/naturecommunications 1
& 2014 Macmillan Publishers Limited. All rights reserved.
T
he metaphase-to-anaphase transition is the critical point in
the cell cycle where the cell commits to separation of sister
chromatids. Mistakes at this stage can lead to aneuploidy
and chromosome breakages, which are features common in
cancer1. Before anaphase, spindle assembly checkpoint (SAC)
monitors correct spindle attachment and biorientation of sister
chromatids2. Once spindle attachment is complete, cohesion
must be eliminated to enable the physical separation of sister
chromatids. This requires cleavage of the protein complex
cohesin by separase and, in some instances, completion of
chromosome decatenation3–7. Loss of topoisomerase activity in
metaphase leads to delayed exit and extensive anaphase
chromosome bridging, often resulting in cytokinesis failure,
although maintenance of limited catenation until anaphase may
be important for sister chromatid structural organization8–10.
Anaphase is initiated by activation of an E3 ubiquitin ligase
complex, the anaphase promoting complex (APC), which directs
protease-mediated degradation of anaphase inhibitors cyclinB1
and securin11. Various mitotic signalling components are
transiently localized to the kinetochore during mitosis and
control of their dynamic association with the kinetochore
generates a diffusible inhibitor of the APC11,12. This inhibitory
complex is maintained until bioriented microtubule engagement
is established for all sister chromatid kinetochores. Kinetochore
signalling components include the checkpoint proteins Bub1,
BubR1 and Mad2 (ref. 13). Other regulatory components present
at the kinetochore include the RZZ complex (Rod, ZW10,
Zwilch)14 and various motor proteins including dynein and
CENP-E15,16. Once all sister chromatids are bioriented, the APC
is activated and anaphase is initiated.
SAC silencing is a complex process and various mechanisms
are involved in regulating anaphase onset. These include the
activation of PP1 phosphatase activity17–19, ubiquitination of
cdc20 by the APC20 and dynein-mediated streaming of
checkpoint components from the kinetochore, a process which
is regulated by the RZZ complex21,22. Regulation of mitotic exit
when biorientation is incomplete is well studied23, but how
anaphase is delayed when sister chromatids retain catenation is
unclear.
DNA catenanes formed during replication are corrected by
topoisomerase II (topoII), which is essential for complete
decatenation of sister chromatids and subsequent segregation in
mitosis24. Topoisomerase IIa (topoIIa) is associated with mitotic
chromosome arms throughout mitosis25 and plays an essential
role in mouse embryonic development as disruption of the
topoIIa gene is lethal at the four- to eight-cell stage where cells
show evidence of mitotic segregation failures26. Consistently,
either inhibition of topoIIa using bis(2,6-dioxopiperazine)
derivatives such as ICRF193 or depletion of topoIIa in human
cells results in anaphase chromosome bridging, leading to
polyploidy and cell death8,27. Persistence of DNA sister
chromatid catenation during anaphase is likely to promote
DNA damage and genomic instability through chromosome non-
disjunction and breakage28. Thus, topoIIa-mediated decatenation
of sister chromatids is required for proper cell division.
A catenation-sensitive delay at the metaphase-to-anaphase
transition has been identified in both vertebrates4,29–31 and
budding yeast32. However, there are few insights into what
signalling molecules are involved in this process and what
relationship this has with the SAC.
Here we demonstrate that protein kinase Ce (PKCe) controls a
pathway required to trigger and maintain the catenation-
dependent metaphase delay characterized by retention of a subset
of SAC regulators. This delay can be overridden without
catenation resolution by PKCe ablation or inhibition, thus
representing a metaphase control point rather than a physical
block to anaphase onset. Using a direct measure of metaphase
catenation, we demonstrate that this PKCe pathway controls
catenation resolution in mitosis. We thereby show that PKCe
becomes engaged when there is excess metaphase catenation, and
that it controls a pathway that delays anaphase entry and
promotes decatenation. We and others have identified trans-
formed cell lines that have a leaky G2 catenation checkpoint33.
We hypothesize that this process acts as a failsafe mechanism to
protect cells that aberrantly enter mitosis with excess catenation.
Importantly, we find that non-transformed cells with a robust G2
catenation arrest do not enter mitosis with catenated sister
chromatids and display no dependence on the PKCe-regulated
pathway, suggesting a potentially excellent therapeutic index for
PKCe intervention in cancer.
Results
PKCe regulates mitotic catenation resolution. We have
reported previously that PKCe is important in completion of
cytokinesis34,35. Here we imaged HeLa cells by time-lapse
microscopy and found evidence of an earlier mitotic defect as a
result of PKCe loss, which manifests as an increase in anaphase
chromosome bridging, demonstrated by an increase in the mean
number of anaphase chromosome bridges by 55.7% (siControl
versus PKCe si1, P¼ 0.0008; Fig. 1a,b). We observe heterogeneity
between the three different small interfering RNAs (siRNAs) used
and attribute this to efficiency of knockdown (Fig. 1a). The
chromatin bridging typically consists of large sections of
Figure 1 | Knockdown of PKCe causes chromatin bridging that is associated with an increase in both metaphase and anaphase catenation.
(a–c) HeLa cells that stably express mCherry-H2B and GFP-Tubulin (HeLa H2B) were imaged by time-lapse microscopy. (a) Graph showing the number of
HeLa-H2B cells that enter anaphase with chromatin bridging. Cells were treated with either control siRNA or one of three different siRNAs that target
PKCe (si1, si2 and si3) and imaged by time-lapse microscopy. Graph shows average of three experiments±s.e.m., n430 per experiment, per condition.
Right panel shows quantification of knockdown to show correlation between knockdown and the frequency of chromatin bridges observed, chart shows
mean ±s.d. (n¼ 3) (b) Stills taken from time-lapse imaging of HeLa-H2B cells after treatment with PKCe si1; time in minutes marked in white. (c) CLEM
image of a Hela H2B cell in cytokinesis showing chromatin in red (arrowed) and juxtaposed electron micrograph sections showing details of this chromatin
bridge. Top right panel shows a higher magnification of the area denoted by the white box in the far right panel, the red arrow shows electron dense
chromatin bridges. (d) Immunoflourescence images of HeLa cells after treatment±PKCe siRNA showing PICH-PS (green), centromeres by ACA staining
(red) and DAPI (blue). Open arrows indicate PICH-positive strands that do not colocalize with DAPI, and closed arrows indicate PICH and DAPI
colocalization, stared open arrow indicates DAPI-positive bridges with no PICH staining. (e,f) PICH-PS are more persistent after PKCe knockdown or
inhibition evidenced by long PICH-PS. Immunoflourescence images of DLD-1 PKCe M486A cells after treatment with NaPP1showing examples of PICH-PS
that are persistent into telophase PICH-PS (red) and DAPI (blue). (f) Chart shows length of PICH-PS measured using Zen software (Zeiss), red line
indicates mean length, each spot represents a single strand (n470). (g, upper panel) Scheme to describe the basis of the catenation spread assay.
(g, lower panel) Representative example images of catenation spread assay with catenated sister chromosomes starred and an example chromosome
enlarged for clarity. (h) Chart shows the percentage of sister chromatids per cell with catenated chromosomes; mean shown by black line (n430 cells,
repeated three times). Scale bars, 5 mm (unless otherwise stated).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6685
2 NATURE COMMUNICATIONS | 5:5685 | DOI: 10.1038/ncomms6685 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
chromatin emanating from both sides of the furrow, often with a
central section that is not marked by mCherry-H2B or
40,6-diamidino-2-phenylindole (DAPI; Fig. 1b,c). We inspected
these structures by correlative light and electron microscopy
(CLEM) and found that the large chromatin sections were linked
together by thin stretches of DNA, which are continuous through
the furrow (Fig. 1c). The mitotic spindle appears to be correctly
attached at the kinetochore as the centromeres segregate
normally, indicating that the bridging portions do not represent
incorrect kinetochore attachments (Fig. 1d). Anaphase chromatin
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bridging persisted into telophase in 61.5% of telophase cells
scored and the centromere section of the chromosome was not
seen in the furrow (Supplementary Fig. 1a). Intriguingly, we did
not see any such chromatin bridging in normal diploid RPE-1
cells after knockdown of PKCe (Supplementary Fig. 1b).
PICH (Plk-1 checkpoint helicase) binds to fine strands of DNA
that span the anaphase plate and are postulated to be associated
with centromeric catenated DNA36. As we observed fine strands
of DNA in the furrow by CLEM (Fig. 1c), we employed PICH as a
marker of ultra-fine strands, to quantify the association between
loss of PKCe and the appearance of these strands. We indeed saw
a change in PICH-positive strands (PICH-PS) after PKCe
knockdown, which increased from 25% of cells in the control
to 64% in cells treated with PKCe si1 (Fig. 1d). This high basal
level of PICH-PS in control cells is corroborated by others37.
We confirmed this finding in a second cell line and exploited the
PKCe M486A gatekeeper mutant. The small molecule NaPP1
binds to very few wild-type kinases due to a steric clash with the
gatekeeper residue in the ATP-binding pocket; PKCeM486A is
inhibited, as the gatekeeper residue has been substituted with a
less bulky alanine35,38. In the DLD-1 PKCeM486A cell line, we
observe an increase in PICH-PS from 16% under basal conditions
to 58% in cells after treatment with NaPP1. These PICH-PS
generally did not co-localize with the DAPI-stained chromatin
bridges (23% colocalization in HeLa and 25% colocalization in
DLD-1 PKCeM486A cells; see Fig. 1d,e), indicating that most of
the PICH-PS can be attributed to ultra-fine stretches of DNA as
seen by others7,36,37,39. In addition to an increase in the number
of PICH-PS, we also observe an increased persistence of these
strands into late anaphase and telophase, and this manifests as
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Figure 2 | RPE-1 hTERT cells have an intact G2 checkpoint but this response is weak in HeLa and DLD-1 cells. (a) RPE-1 hTERT cells have a
robust G2 checkpoint shown by FACS analysis. Cells were treated for 24 h with the indicated inhibitors and analysed by FACS. Scatter charts
show DNA content plotted against MPM-2 intensity to measure the number of cells that escape the G2 checkpoint into a nocodazole arrest in mitosis.
The percentage of MPM-2-positive cells was analysed and plotted in b–d for the three different cell lines as indicated (chart shows average of three
experiments ±s.e.m., n410,000 cells counted per condition).
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very long PICH-PS after PKCe inhibition or knockdown
(Fig. 1e,f). Chromosome bridging and PICH-PS have been
associated with an increase in anaphase catenation7,36,37,39,40,
we therefore investigated whether the increase in chromosome
bridging seen after PKCe knockdown correlates with an increase
in metaphase catenation.
DNA catenation in mitosis can trigger a delayed exit from
mitosis29–31 and there may be a varying requirement in different
cell lines for decatenation in metaphase, dependent on the fidelity
of the G2 catenation checkpoint41,42. We therefore sought to
establish the cause of the anaphase bridging that we observed on
PKCe knockdown. We hypothesized two non-exclusive scenarios:
(i) that there may be a high basal level of metaphase catenation in
these cell lines, which is inefficiently resolved due to the loss of a
PKCe-promoted decatenation pathway or (ii) that PKCe
may operate a checkpoint-associated response to metaphase
catenation, which would normally implement a metaphase delay,
providing time for decatenation and preventing bridging in
anaphase.
To address whether there is an increase in mitotic catenation,
we directly measured the degree to which sister chromatids were
catenated in prometaphase. In this assay, we monitor sister
chromatid catenation by enabling the removal of centromeric
cohesin and then viewing the chromosome formations. Centro-
meric cohesion is protected from removal during prophase by
Sgo-1 (ref. 43). When Sgo-1 is targeted, sister chromosome
cohesion is lost resulting in mitotic cells with single sister
chromatids. The extent to which sister chromatids are catenated
is revealed as a tethering of sister chromatid arms (Fig. 1g and
Supplementary Fig. 2). The frequency of this tethering increases
with knockdown of topoIIa by siRNA as expected
(Supplementary Fig. 2), and in confirmation that the structures
seen here reflect catenation, we found that addition of
recombinant topoIIa ex vivo reversed the tethering phenotype
observed (Fig. 1h).
We applied this assay to determine whether PKCe plays a role
in metaphase decatenation. Interestingly, we saw an increase in
metaphase catenation after PKCe knockdown using siRNA
(Fig. 1g,h) and this could be recovered using recombinant
topoIIa, suggesting that the tethering seen in this assay represents
catenation. We confirmed this using the DLD-1 PKCeM486A cell
line and find that specific inhibition using NaPP1 also caused an
increase in sister chromatid catenation in metaphase (Fig. 1h)
In contrast to our findings above in the HeLa and DLD-1 cells,
PKCe knockdown in the non-transformed RPE-hTERT cells did
not increase either metaphase catenation or PICH-PS (Fig. 1h)
and, in fact, out of over 100 fields of view revealing at least 30
early anaphase cells, we did not see any PICH-PS. This is in line
with our observation that we also do not see an influence of PKCe
on chromatin bridging in RPE-1 cells (Supplementary Fig. 1b).
We did observe an increase in metaphase catenation after
TopoIIa knockdown in this cell line, which is expected, as
TopoIIa is essential for both decatenation and arrest at the G2
catenation checkpoint44,45. We could not rescue this increase in
catenation, as it was much more pronounced than the other
two cell lines. Given this evidence, we hypothesized that the
PKCe-dependent phenotype seen in HeLa and DLD-1 cells may
be due to a requirement for a metaphase decatenation pathway in
response to excess catenation persisting from G2.
To investigate the possible G2 origin of the metaphase
catenation, we carried out a fluorescence-activated cell sorting
(FACS) analysis to compare the robustness of the G2 checkpoint
in the three cell lines discussed above. We used ICRF193 to assay
the G2 checkpoint response to catenation and bleomycin to
measure the checkpoint response to DNA damage41,46. In line
with our previous observations, RPE1-hTERT arrest robustly in
G2 when treated with either ICRF193 or bleomycin (Fig. 2a,b).
This could be weakened using an Ataxia telangiectasia mutated/
ATM-RAD3-related inhibitor as expected. Both HeLa and DLD-1
cells had a more leaky response to either ICRF193 or bleomycin,
indicating that they both have a weakened G2 catenation
checkpoint as predicted.
PKCe is required to trigger the metaphase catenation delay.
Excessive catenation in mitosis causes a delay to anaphase entry29–
31, and as we see evidence of catenation entering anaphase in our
transformed cell lines when PKCe is compromised, we postulated
that the metaphase catenation delay may also be abrogated after
loss of PKCe. In agreement with Huang et al.47, we find that the
topoIIa inhibitor ICRF193 triggers a transient metaphase delay of
94±6.6 min (Po0.0001) in HeLa cells and 119±7.1 min,
(Po0.0001) in DLD-1 cells (Fig. 3a–d). In these assays, we use
time-lapse microscopy to record images of either DLD-1 or HeLa
cells expressing mCherry-Histone2B and record the time taken
from metaphase alignment to sister chromatid separation in
anaphase. In the presence of ICRF193, the anaphase achieved is
very unequal and more difficult to detect as shown in Fig. 3d. This
is likely to be due to an excess of catenation preventing sister
chromatid separation. Interestingly, we find that this metaphase
delay is very dependent on PKCe and using siRNA we see a
reduced metaphase delay by 54±7 min (Po0.0001) in HeLa cells
(Fig. 3a,b). Consistently, knockdown or inhibition of PKCe in
DLD-1 cells also bypasses this metaphase delay and decreases the
time spent in mitosis by 58±8 min (Po0.0001; Fig. 3c,d and
Supplementary Fig. 1d). In addition to using NaPP1 to inhibit
PKCe in these assays, we also confirmed the specificity of the PKCe
siRNA by recovering the phenotype with an siRNA-resistant PKCe
construct. In this system, the metaphase delay is recovered as
shown by a decrease in the metaphase transition speed of
56±11 min (Po0.0001) following tetracycline induction of the
siRNA-resistant construct, confirming the specificity of the siRNA
phenotype (Supplementary Fig. 1c). We also investigated whether
both the decatenation pathway and the requirement for PKCe
could be triggered after the cells had entered mitosis by inhibiting
topoIIa and PKCe once cells enter mitosis. As with the data above,
we induce a delay to metaphase exit by adding ICRF193 once cells
have entered prophase and this is again lost when PKCe is
inhibited. This confirms that these cells require PKCe activity to
trigger/maintain a metaphase delay in mitosis (Supplementary
Fig. 1d).
In addition to a dependence on PKCe to trigger a metaphase
delay in response to a topoIIa inhibitor, we also see an increase in
the basal metaphase transition speed in HeLa cells after
knockdown of PKCe using the most efficient siRNA (PKCesi1)
of 5 ±1.1 min (Po0.0001) compared with the control (Fig. 3e,f).
We do not observe any difference in the time taken from
prometaphase to metaphase, indicating that chromosome con-
gression to the metaphase plate is not affected by PKCe
knockdown. We can again recover this phenotype using the
siRNA-resistant PKCe construct, indicating that the effect is
specific to PKCe (Po0.005; Supplementary Fig. 1c).
As with decatenation, we do not see PKCe dependence in
RPE-1 cells under basal conditions (Supplementary Fig. 1e) and as
HeLa cells have high levels of metaphase catenation and PICH-PS
in anaphase (Fig. 1h and Supplementary Fig. 2), we propose that
the increase in basal transition speed is the result of abrogation of
a catenation delay that is routinely engaged by HeLa cells having
a ‘leaky’ G2 catenation checkpoint. These results together suggest
that the catenation resolution pathway and the arrest triggered by
detection of metaphase catenation may be intrinsically linked, as
both are highly dependent on PKCe.
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We tested whether we could induce a dependence on PKCe in
RPE-hTERT cells by weakening the G2 catenation checkpoint,
to allow entry of catenated DNA into mitosis. We used an
Ataxia telangiectasia mutated/ATM RAD3-related inhibitor48
and, in line with our findings, this causes cells to enter mitosis
even when ICRF193 is present and these cells then arrest in
G
siScramble
PKCε si1
siScramble+ ICRF193
PKCε si1 + ICRF193
C
um
ul
at
iv
e 
fr
eq
ue
nc
y 
(%
)
HeLa mCherry-H2B eGFP-tubulin cells
siScramble + ICRF193
siPKCε+ ICRF193
0 10 Mins 20 Mins 30 Mins 40 Mins 50 Mins
Cytokinesis0 10 Mins 20 Mins 30 Mins 40 Mins
mCherry-H2B
mCherry-H2B
GFP-tubulin
Merge
mCherry-H2B
mCherry-H2B
GFP-tubulin
Merge
0 50 100 150 200
0
20
40
60
80
100
a
b
0 10 Mins 20 Mins 30 Mins 40 Mins 50 Mins
siScramble
mCherry-H2B
mCherry-H2B
GFP-tubulin
Merge
mCherry-H2B
mCherry-H2B
GFP-tubulin
Merge
siPKCε
0 10 Mins 20 Mins 30 Mins 40 Mins 50 Mins
g
c
e
f
Time metaphase – anaphase onset 
DLD-1 PKCε M486A-eGFP cells
HeLa mCherry-H2B eGFP-tubulin cells
0 10 20 30 40
0
20
40
60
80
100
0 10 20 30 40
0
20
40
60
80
100
siScramble
0 100 200 300
0
20
40
60
80
100
DMSO
NaPP1
ICRF193
ICRF193 + NaPP1
Time NEBD – metaphase 
Time metaphase – anaphase onset 
PKCε si1
PKCε si2
PKCε si3
Time in prometaphase
Time in metaphase
siScramble
PKCε si1
PKCε si2
PKCε si3
Time metaphase – anaphase onset 
eGFP-
PKCε M486A 
eGFP-
PKCε M486A 
108 Mins0
0 28 Mins
28 Mins
52 Mins
52 Mins
80 Mins
80 Mins
108 Mins
104 Mins
204 Mins
d
NaPP1+ ICRF193
DMSO + ICRF193
Figure 3 | Knockdown of PKCe causes cells to enter anaphase prematurely when challenged by catenation. The fidelity of the metaphase catenation
arrest was assessed by time-lapse microscopy. (a,b) HeLa-H2B cells were treated for 48 h±siRNA targeting PKCe. Cumulative frequency chart (a) and
representative stills, time in minutes marked in white (b) showing time taken in minutes from metaphase-to-anaphase±5 mM ICRF193. (c,d) Inhibition of
PKCe M486A in DLD-1 cells abrogates the metaphase catenation delay as illustrated by cumulative frequency chart (c) and representative stills (d),
showing time taken in minutes from metaphase to anaphase after treatment with NaPP1±5 mM ICRF193. (e–g) HeLa-H2B cells were treated with either
control siRNA or one of three different siRNAs that target PKCe (si1, si2 and si3). (e,f) Cumulative frequency charts showing the time spent in either
metaphase (e) or prometaphase (f), and representative stills from the time-lapse videos, time in minutes marked in white (g). For all live-cell experiments,
n430, all experiments repeated three times. Scale bars, 5 mm.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6685
6 NATURE COMMUNICATIONS | 5:5685 | DOI: 10.1038/ncomms6685 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
metaphase for an extra 65.5±3.7 min (Po0.0001) compared with
the control (Supplementary Fig. 1f,g). In line with our
observations in HeLa and DLD-1 cells, this delay is abrogated
by PKCe knockdown using siRNA by 19±6.4 min (P¼ 0.0055),
suggesting that RPE cells are also dependent on PKCe if they
encounter catenation in mitosis.
Involvement of PKCe in other perturbations of the SAC. The
evidence above suggests that PKCe is involved in modulating exit
from metaphase under conditions of catenation stress. To address
whether this PKCe control is triggered by other known perturba-
tions of anaphase entry, we assayed mitotic transition times in
HeLa cells, DLD1 and RPE-hTERT cells under various conditions
that perturb the mitotic spindle. Nocodazole treatment was used to
assess the fidelity of the SAC response to unattached kinetochores,
the Eg5 inhibitor monastrol was used to assess the SAC response to
non-bioriented, monopole spindles49. All three cell lines tested
maintained a robust SAC arrest after loss of PKCe in response to
nocodazole (Fig. 4a,b and Supplementary Fig. 3a,e) or monastrol
(Fig. 4a,b and Supplementary Fig. 3a,e), indicating that PKCe is
not required for this aspect of the SAC arrest. Taxol was also used
at various concentrations to assess the effect of stabilization of the
spindle to different degrees. The SAC arrest was entirely insensitive
to PKCe modulation in DLD-1 and RPE-1-hTERT cells, indicating
that this SAC trigger is not dependent on PKCe. However, in HeLa
cells the arrest was weakened on treatment with PKCe siRNA
(Supplementary Fig. 3c,d). This one contradictory result indicates
that PKCe is not an absolute requirement for taxol-mediated
mitotic arrest, but can become engaged in some circumstances.
Importantly, PKCe dependence on ICRF193-induced metaphase
delay was uniformly robust in the transformed cell lines after
treatment with either PKCe siRNA or a PKCe inhibitor, Blu557
(Compound 18 (ref. 50), Fig. 3 and Supplementary Fig. 1f,g).
Catenation is therefore the only penetrant trigger for the PKCe-
dependent mitotic exit that we have tested.
PKCe regulation of SAC silencing. Catenation appears to
implement a PKCe-dependent delay to anaphase entry; we
therefore sought to understand whether and how PKCe influ-
ences exit from the SAC under conditions of high catenation.
We addressed this by determining whether key kinetochore
components of the SAC came under PKCe control in catenation-
challenged, transformed cells. Previous reports regarding kine-
tochore occupation during a catenation-triggered metaphase delay
are mixed4,29; however, in accordance with Toyoda and Yanagida4
we find the level of Mad2 is below the lower detection limit, but
observe retention of intense Bub1 and BubR1 staining in both the
DLD-1 and HeLa cell models (Supplementary Fig. 4a–c).
To assess the effect of inhibiting PKCe on localization of the
SAC proteins remaining on the kinetochore, we arrested cells in
metaphase using ICRF193 and added the PKCe inhibitor Blu577
(Compound 18 (ref. 50)) for 20 min to establish whether PKCe
plays a dynamic role in maintaining the checkpoint proteins on
the kinetochore. Inhibition of PKCe causes acute loss of BubR1
and Bub1 from kinetochores of ICRF193-treated cells
(Supplementary Fig. 4a,b). As biorientation is achieved at this
point, this is consistent with a role for PKCe in triggering a delay
to the release of BubR1 and Bub1 from the kinetochore when
resolution of decatenation has not been achieved.
PKCe inhibition modulates microtubule-dependent streaming
of ZW10. The RZZ complex is known to play a role in mitotic
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Figure 4 | Knockdown of PKCe using siRNA does not affect the SAC arrest in DLD-1 cells. (a–d) DLD-1 cells were treated with various SAC triggers
and the fidelity of the SAC arrest was measured after loss of PKCe. (a,b) DLD-1 parental cells or DLD-1 PKCe M486A cells were treated with 100 mM
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For all live-cell experiments, n430, all experiments repeated three times.
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exit and its depletion is associated with increased segregation
errors resulting in multinuclear cells51. All of the components of
the RZZ complex are localized to the kinetochore during
prometaphase and bind to Zwint and Knl1 (refs 51,52). Our
experiments indicate that both ZW10 and Zwilch change their
steady-state localization when delayed by catenation in
metaphase and become undetectable at the kinetochore
(Supplementary Fig. 5a,b). Dynein is similarly reduced in cells
delayed in response to ICRF193 but not nocodazole, suggesting a
dependence on the mitotic spindle for this reduction in signal at
the kinetochore (Supplementary Fig. 5c). In both of these
conditions, Bub1 and Zwint remain attached to the
kinetochore, indicating a selective change in the apparent
binding affinity of the RZZ complex and not a general
disassembly of kinetochore complexes. These altered properties
suggest that under conditions of excess catenation, the RZZ
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complex and dynein may be actively removed from the
kinetochore indicative of kinetochore microtubule attachments53.
We investigated whether the RZZ complex was actively
streaming on the spindle by using FLIP (fluorescence loss in
photobleaching) to measure ZW10 kinetochore dynamics. Using a
HeLa cell model, which stably expresses GFP-ZW10 at a level that
does not perturb normal mitotic transition, we repeatedly bleached
cytoplasmic GFP-ZW10 and measured its rate of loss from the
kinetochore (Fig. 5a,b). As expected, cells that are delayed with
metaphase catenation have a faster kinetochore ZW10 turnover rate
than cells arrested using nocodazole (Fig. 5c). This indicates that
stable microtubule attachments are made at this point and correlates
with our finding that levels of Mad2 are low (Supplementary
Fig. 4c)53. PKCe inhibition further decreases this half-life only in
cells arrested using ICRF193, indicating that PKCe may have some
input into the regulation of kinetochore stripping (Fig. 5d).
Perturbation of dynein-mediated kinetochore stripping can be
sufficient to prevent anaphase entry and thus we tested whether
PKCe feeds into this pathway54. Erythro-9-3-(2-hydro-
xynonyl)adenine (EHNA) inhibits dynein ATPase activity and
prevents cytoplasmic fluxing of dynein and its substrates55. We
tested whether EHNA could prevent the kinetochore turnover of
ZW10 in our system, to assess whether this was dominant over the
exit from mitosis induced by PKCe inhibition. Interestingly, the
decrease in half-life induced by PKCe inhibition can be prevented
by inhibiting dynein (Fig. 5d). This indicates that mitotic exit
triggered by PKCe inhibition is a dynein-dependent process.
PKCe-mediated regulation of kinetochore SAC components.
As we can recover the effect of PKCe on ZW10 kinetochore
turnover by dynein inhibition, we hypothesized that the mitotic
exit triggered by PKCe inhibition may also be a dynein-
dependent process. We found that in metaphase-delayed cells,
acute inhibition of dynein does indeed block the degradation of
cyclinB1 induced by acute PKCe inhibition in metaphase cells
(Fig. 5e–g). We also investigated whether loss of BubR1 after
PKCe inhibition is prevented, given that others have shown that
this regulator can be stripped by dynein22,54,56. Interestingly, we
find that the loss of BubR1 from the kinetochore after PKCe
inhibition is also a dynein-dependent process (Fig. 5g).
It is unclear whether the effect of inhibiting dynein in these
assays is to directly prevent ZW10 streaming from the
kinetochores or whether kinetochore microtubule binding is
perturbed, because dynein is also known to play a role in
stabilizing kinetochore microtubule interactions56. We see a small
increase in prometaphase cells with dispersed metaphase plates,
indicating that the cells transitioning from prometaphase to
metaphase during the 20-min EHNA treatment do not fully
congress to the metaphase plate and these cells have intense Mad2
signal (Supplementary Fig. 4e). This is in agreement with Varma
et al.56 who showed abnormal spindle equator orientation and
oscillation of kinetochore pairs after dynein perturbation. We find
that Mad2 is not stabilized on fully congressed metaphase
kinetochores after EHNA treatment, indicating that these spindle
attachments may be maintained (Supplementary Fig. 4d,e). This
is in contrast to a short incubation with the microtubule
depolymerizing agent nocodazole, which quickly causes
recruitment of Mad2 to the kinetochores (Supplementary Fig. 4f).
Discussion
The evidence here defines a PKCe-dependent pathway as a
conditional player in exit from the SAC that monitors appro-
priate sister chromatid decatenation (see Fig. 6 for working
model). As part of this response, PKCe may trigger a resolution
pathway as evidenced by an increase in catenation in mitosis after
loss of PKCe activity. This catenation manifests as chromatin
bridging and PICH-positive strands in anaphase. We further find
that PKCe is required to trigger the metaphase delay in response
to catenation, indicating that PKCe is required for a global
response to metaphase catenation. Interestingly, it appears that
this is particularly important in certain transformed cells, which
have a weak G2 catenation checkpoint and therefore a heightened
requirement for mitotic decatenation. This acquired, emergent
behaviour suggests a transformed cell-specific vulnerability to
PKCe inhibition.
PKCe plays an essential role in cytokinesis in some
systems34,35,57. The anaphase bridging observed here correlates
with cytokinesis failure, indicating that there may be a link
between the two phenotypes. Close examination of the
cytokinesis phenotype, using a very specific chemical genetic
inhibitor, has shown that a cytokinesis defect can be induced by
inhibition of PKCe once the cell is already in telophase. This
suggests that although these phenotypes may be related, they can
be triggered independently. The cytokinesis phenotype described
previously may therefore be exacerbated by a failure to complete
decatenation after PKCe knockdown and this may also explain
the cell-type-specific penetrance of the phenotype34.
The G2 catenation checkpoint is defective in a variety of
different cancer cell lines33. We have shown that only cells with a
leaky G2 catenation checkpoint enter mitosis with detectable
basal catenation. These cells display a strong dependence on
PKCe for the resolution of catenation in mitosis to avoid
chromosome disjunction. We therefore propose that PKCe is
working directly in mitosis to protect cells from anaphase entry
with catenated sister chromatids, although we cannot rule out
that PKCe has additional roles in other stages of the cell cycle.
We show that normal (non-transformed) cells arrest robustly
before mitosis when challenged by catenation, and that this arrest
is not dependent on PKCe. We therefore suggest that this
Metaphase Anaphase
Catenation Disjunction
errors
G2-M boundary
Catenation
resolved
G2 checkpoint
functional
Catenation
persistent
G2 checkpoint
dysfunctional
BUB1
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RZZ
PKCε
Figure 6 | Model of the PKCe-dependent metaphase catenation delay.
There is a catenation checkpoint at the G2-mitosis boundary, which would
normally trigger resolution of excess DNA catenation before entry into
mitosis. If this process fails, as is the case in some transformed cells,
there is a failsafe in metaphase, which is dependent on PKCe to both
implement a delay and to trigger catenation resolution. This pathway is
activated when there is persistent catenation after the spindle is fully
aligned at the point of mitotic exit and is effected through a dynein-
dependent modulation of the SAC. In cells with both an abrogated
G2 catenation checkpoint and loss of PKCe, cells exit mitosis prematurely
with disjunction errors caused by sister chromatid catenation.
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provides an explanation for the conditional requirement for
PKCe in a subset of cell lines.
The evidence indicates that PKCe is an apparently universal
modulator of the metaphase catenation delay in the transformed
cell lines tested and also in the non-transformed RPE cell line
when a dependence is triggered using inhibitors of the G2
catenation checkpoint. This appears to operate predominantly
independently of the arrest triggered by other perturbations that
influence the SAC. However, there was one interesting outlier,
where in HeLa cells the mitotic arrest induced by taxol shows an
interaction with the PKCe-dependent pathway and was weakened
on loss of PKCe. This was not the case in other cell lines tested. It
is possible that a direct effect of taxol on topoIIa activity may
contribute to this complexity58 or perhaps that the PKCe pathway
may be influencing a subtle taxol-inducible property to which
HeLa cells are particularly sensitive. It has been shown by others
that disruption of TopoIIa can interfere with tension sensing,
which may provide some explanation for an interaction with the
taxol-mediated arrest, although not for the discrepancy seen
between different cell lines4,59. Indeed, a tension-mediated
property may provide some basis for the mechanisms involved
in detection of mitotic catenation and how this is mediated
through the SAC.
In support of a possible role for tension sensing, we and others
show that the metaphase delay invoked by catenation is
characterized by high levels of BubR1 and undetectable Mad2
at the kinetochore4. Acute inhibition of PKCe causes rapid loss of
BubR1 from the kinetochore along with CyclinB1 degradation,
indicating mitotic exit. This mitotic exit is dependent on dynein
and is consistent with a role for PKCe in regulating the very last
stages of disassembly of the mitotic checkpoint via regulation of
dynein-dependent stripping of BubR1. CyclinB1 levels remain
high and Mad2 levels low, suggesting that kinetochore BubR1
may be sufficient to impart a transient delay to APC activation in
these circumstances, although we cannot rule out that low or
transient kinetochore Mad2 is providing a diffusible APC
inhibitor11. The RZZ complex and dynein are stripped from the
kinetochore during the catenation delay, indicating that spindle
attachments are formed during this time, and this is supported by
the timely congression of the metaphase plate along with
undetectable Mad2 on the kinetochore.
It is not known whether kinetochore BubR1 is sufficient to
inhibit the APC alone, although it is a strong candidate as it has a
rapid kinetochore–cytoplasm exchange and is an inhibitor of the
APC12,60. Notably, Huang et al.61 show that retention of BubR1
on the kinetochore using a phosphomimetic mutant can delay
anaphase onset. This is characterized by low levels of kinetochore
Mad1 and a delay of around 2 h with full metaphase plate
congression. This is similar to the delay shown here after
inhibition of topoIIa.
Exit from the SAC can be modulated by dynein- and RZZ
complex-regulated stripping of checkpoint proteins from the
kinetochore, allowing SAC silencing. We show evidence that the
mitotic exit implemented by PKCe inhibition is a dynein-
dependent process and show that the metaphase arrest stimulated
by excess metaphase catenation is characterized by stripping of
both the RZZ complex and dynein from the kinetochore along
with ZW10. We show that PKCe can modulate the rate of ZW10
streaming by adding a PKCe-specific inhibitor during live-cell
imaging, eliciting an increase in the rate of ZW10 streaming and
showing that PKCe is playing an active role in mitosis.
Reports regarding whether dynein-dependent streaming can
regulate BubR1 kinetochore retention are mixed22,62. Others have
shown that BubR1 is retained on the kinetochore when dynein-
dependent stripping is disrupted by point mutations in Zwint54
or by truncations of dynein itself56, showing dynein does regulate
kinetochore BubR1 in some circumstances. Here we show loss of
kinetochore BubR1 after PKCe inhibition before anaphase entry
and show that this can be prevented by inhibiting dynein. On
inhibition of dynein, we see no recovery of kinetochore Mad2,
indicating that kinetochore BubR1 may be sufficient to impart the
transient metaphase delay that we observe in response to
catenation in metaphase.
It is unclear precisely what triggers the metaphase response to
catenation. TopoIIa appears to be intrinsically required for both
resolution and catenation detection in both metaphase and G2. In
both instances, deletion of the enzyme results in an abrogated
catenation checkpoint and progression with non-disjunction to
the next cell cycle phase44,45. ICRF193 is a class 2 topoismerase
inhibitor that blocks topoIIa in a catalytically inactive state; it
does not cause DNA damage directly as TopoIIa is retained in a
conformation in which it cannot induce double-stranded breaks.
However, this does not rule out DNA damage as a result of
continued transit through the cell cycle with excess catenation,
which may contribute to the mixed reports regarding the
induction of DNA damage markers45,63. Inhibition with this
drug triggers both the G2 and the mitotic checkpoint29,45. It
therefore seems that the presence of TopoIIa in a particular
catalytic state may be important for activation of both of the
checkpoints. In accordance with this, Furness et al.44 have
isolated various catalytically inactive mutations of yeast top2 that
differentially inactivate the mitotic catenation checkpoint,
suggesting that checkpoint signalling is propagated through
topoisomerase enzyme cycles and not through the DNA lesion
itself44.
Untangling this intriguing relationship with known functions
of the SAC and also investigating what other replication stress-
induced segregation perturbations may be detected and regulated
in mitosis may prove to be important in our global understanding
of the mechanisms used to protect cells from DNA damage and
aneuploidy. Here we have identified PKCe as a conditional player
in the mitotic checkpoint, which is engaged only in the context of
metaphase catenation and serves to delay anaphase transition
protecting from cell division failure (Fig. 6). This conditional
engagement provides a unique opportunity for intervention in
those tumours dependent on PKCe due to a weak G2 catenation
checkpoint64–67. The definition of this layer of SAC control opens
up a promising avenue to new mitotic cancer therapeutics
capitalizing on our growing understanding of the complexities
involved in regulation of the cell cycle.
Methods
Reagents. All reagents, including Nocodazole, ICRF193, Colcemid, Taxol and
Nocodazole, were purchased from Sigma Aldrich unless otherwise stated. ATM/
ATR inhibitors were purchased from Calbiochem. BLU577 was kindly provided by
Dr Jon Roffey, Cancer Research Technology, UK.
Cell culture. HeLa cells cultured in DMEM (Gibco)þ 10% FCS. For siRNA
transfections, HiPerfect (Qiagen) was used according to the manufacturer’s
recommendations; all siRNAs were used at a final concentration of 10 nM.
Tetracycline-inducible 293 cell lines were generated using the T-Rex Flp In system
(Invitrogen) according to the manufacturer’s instructions. To induce GFP–PKC
expression, HEK 293 cells were cultured in DMEM containing 10% FCS and
tetracycline (100 ng ml 1) for 24 h before assay.
For siRNA transfections, HiPerfect (Qiagen) was used according to the
manufacturer’s recommendations; all siRNAs were used at a final concentration of
10 nM. The following SmartPOOLs were purchased from Dharmacon: PKCe si1:
Cat. D-004653-01 (50-gggcaaagaugaaguauau-30); PKCe si3: Cat. J-004653-08-0050
(50-GACGUGGACUGCACAAUGA-30); siBubR1Smartpool set of 4: Cat.
LU-004101-00-0002 (50-CAAUACAGCUUCACUGAUA-30 , 50-GCAAUGAGC
CUUUGGAUAU-30 , 50-GAAACGGGCAUUUGAAUAU-30 , 50-GAUGGUGAAU
UGUGGAAUA-30); siMad2 Smartpool set of 4: Cat. D-003271-05 (50-GAAAGA
UGGCAGUUUGAUA, 50-UAAAUAAUGUGGUGGAACA-30 , 50-GAAAUCCG
UUCAGUGAUCA-30 , 50-UUACUCGAGUGCAGAAAUA-30); si topoIIa
Smartpool set of 4: Cat. J-004239-09 (50-GGUAACUCCUUGAAAGUAA-30 ,
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50-GGAGAAGAUUAUACAUGUA-30 , 50-GAUGAACUCUGCAGGCUAA-30 ,
50-CGAAAGGAAUGGUUAACUA-30); siSgo1 Smartpool set of 4: Cat. D-015475-
17 (50-UGUGAAGGAUUUACCGCAA-30 , 50-CAGCCAGCGUGAACUAUAA-30 ,
50-UGAAAGAAGCCCAAGAUAU-30 , 50-CAUCUUAGCCUGAAGGAUA-30).
The remaining olionucleotides were purchased from Qiagen: PKCe si2: Cat.
S100287784 (50-cccgaccatggtagtgttcaa-30); siControl: cat. 1027310 (50-AATTCTC
CGAACGTGTCACGT-30).
Microscopy. For videomicroscopy experiments, cells were cultured on LabTek
chambered coverglass slides (Nunc) in Leibovitz CO2-independent media (Gibco).
A low light level inverted microscope (Nikon TE2000) imaging system equipped
with a laminar-flow heater to maintain a constant temperature of 37±0.01 C, a
PlanFluor 40 DIC lens and a Xenon lamp for fluorescent excitation. Images were
taken using a high quantum efficiency charge-coupled device camera (Andor Ixon)
every 4 min. Other images were taken using an inverted laser scanning confocal
microscope (Carl Zeiss LSM 780) equipped with a  63 Plan-APOCHROMAT
DIC oil-immersion objective. For all experiments where live cell time lapse was
carried out on individual cells, n430, as this was the maximum number of cells
that could be imaged in multiple position experiments with 3–4 min time points.
Fast time points were required to capture all phases of mitosis and to capture
transition time information. The experiments were repeated three times.
For FLIP experiments, an inverted laser scanning confocal microscope (Carl
Zeiss LSM 780) equipped with a  63 Plan-APOCHROMAT DIC oil-immersion
objective was used. HeLa cells that stably express GFP-ZW10 were used. Individual
cells were alternatively imaged and bleached in a cytoplasmic 2-mm radius circle
every 16 s, acquiring a 5 2 mm Z-stack to capture all kinetochores. The laser
power was kept consistent between experiments at 65 W. Z-stack images were
summed and time-lapse series were analysed using Metamorph software
(Molecular Devices). Kinetochore-localized GFP-ZW10 intensity time courses
were collected using Metamorph (Molecular Devices) and interpolated using
Mathematica (Wolfram). The following exponential function was used:
Ieþ I1*Exp[ t/t1], where Ie¼ background intensity, I1¼ initial intensity,
t¼ time (s) and t1¼ time constant. Images were also collected with bleaching
outside the cell to assess the effect of imaging to the half-life of GFP-ZW10. The
mean of these values were used to correct the T1 values derived from FLIP
experiments to achieve a more accurate representation of GFP-ZW10 half-life
using the following function: T1¼ (TcT2)/T2Tc), where T1¼GFP-ZW10 time
constant, T2¼ slow decay caused by imaging, Tc¼ sum of T1 and T2. T1 half-life
values were obtained by multiplying these values by (1/ln(0.5)). ZW10 kinetics
were measured for at least ten cells per condition and this sufficient to control for
biological variability.
For CLEM, cells were grown on photo-etched gridded coverslips and fixed in
4% paraformaldehyde in 0.1 M PBS. Cells of interest were identified and imaged
using fluorescence and phase contrast microscopy after knockdown of PKCe using
siRNA. Cells were then fixed in 2  5% glutaraldehyde/4% paraformaldehyde in
0.1 M Phosphate Buffer for 1 h. The samples were post-fixed in reduced osmium
tetroxide, stained with tannic acid, dehydrated stepwise to 100% ethanol and
embedded in epon. The cells of interest were relocated on the block face and serial
sections (B70 nm) were cut using an Ultracut UCT ultramicrotome (Leica
Microsystems UK), collected on formvar-coated slot grids and post-stained with
lead citrate. Serial sections were viewed using a Tecnai G2 Spirit 120 kV
transmission electron microscope (FEI Company) and an Orius charge-coupled
device camera (Gatan UK).
Immunofluorescence and immunoblotting. For immunofluorescence experi-
ments, cells were grown on 13 mm poly-L-lysine (Sigma-Aldrich)-coated glass
coverslips and fixed with 4% paraformaldeyhyde/PBS for 15 min. Cells were then
permeabilized with 1% Triton X-100 (Sigma Aldrich), blocked using 1% BSA
(Sigma Aldrich) and probed using the following primary antibodies, all diluted at
1:100 in 1% BSA/PBS: rabbit anti-BubR1 (Cell Signaling Technology D32E8),
sheep anti-Bub1 (ref. 68) (SB1.3) (courtesy of S. Taylor), mouse anti-cyclinB1
(Santa-Cruz Sc-245), mouse anti-phosphoH2A.X (Millipore JBW301) and mouse
anti-PICH (Millipore 04-1540). For Triton X-100 pre-extraction assays, cells were
grown on 13 mm coverslips and staining was carried out as above, except they were
simultaneously fixed and permeabilized using 2% paraformaldeyhyde 1% Triton
X-100/PBS for 30 min. The following primary antibodies were used in these assays:
sheep anti-Bub1 (ref. 68) (SB1.3) (courtesy of S. Taylor), rabbit anti-Mad2
(Bethyl Laboratories A300-301A), mouse anti-ZW10 (AbCam ab53676), mouse
anti-Zwilch (Sigma Aldrich C1C9), rabbit and Zwint (AbCam ab84367), mouse
anti-PICH (Millipore 04-1540) and human anti-Centromere (ACA) (Antibodies
Inc.15-234-0001). All coverslips were mounted using ProLong Gold with DAPI
(Invitrogen).
Immunoblotting was carried out by lysing samples using LDS sample buffer
(Invitrogen) and resolving protein by SDS–PAGE using NuPAGE Bis-TRIS
gradient gels (Invitrogen). Samples were then transferred to polyvinylidene
difluoride membranes (Amersham) and probed using targeted antibodies and
Luminata chemiluminescence detection system (Millipore). The following
antibodies were used in these assays, all diluted at 1:1,000 in 1% BSA/PBS/0.05%
TWEEN-20: rabbit anti-PKCe (Santa Cruz sc-214), mouse anti-topoIIa (Millipore
Mab4197), mouse anti-alpha-tubulin (Sigma T5168), mouse anti-PICH (Millipore
04-1540), rabbit anti-Mad2 (Cell Signaling Technology D8A7) and mouse anti-
BubR1 (NovisBio NB100-353BR1). Band densitometry was carried out using Image
J software and normalized to a tubulin loading control.
FACS analysis of G2 and mitotic cells. To determine the permeability of the
checkpoint, we added nocodazole to capture the cells that pass through the G2
checkpoint into mitosis. We measured the number of cells that were arrested in
mitosis at the end of this assay by staining with propidium iodide to measure DNA
content and an MPM-2 antibody to measure the number of cells in mitosis69. Cells
were treated with various combinations of 1 mM nocodazole, 100 nM ATM
inhibitor, 10mM ATR inhibitor, 10mM ICRF193 and 10 mM bleomycin for 24 h.
Cells were fixed in ice cold 70% ethanol for 24 h and stained with 50 mg ml 1
propidium iodide and 100 mg ml 1 RNAase to analyse DNA content.
Cells were then stained with a MPM-2 antibody that is directly conjugated to
Alexa 633 (Millipore 16–220) for 2 h at room temperature and fluorescence
intensity was measured using a using FACS Calibur (Becton Dickinson). This data
was then analysed using the FlowJo software.
Quantification of immunofluorescence images. Imaging was carried out using
Carl Zeiss LSM 780 confocal microscope equipped with a  63 Plan-APOC-
HROMAT DIC oil-immersion objective and serial 1 mm Z-sections with a 1mm
pinhole were taken to ensure full coverage of chromatin region. All image quan-
tification was carried out using Metamorph image analysis software (Molecular
Devices). Z-sections were summed and corrected for background signal (area with
no cell). An inclusive threshold was then chosen to include all kinetochore signal in
the positive control and applied to all images. Total integrated intensity for the
chromatin region after thresholding was then measured for each cell. At least ten
cells were measured for each condition and this is sufficient to control for biological
variability.
Catenation spread assay. For measurement of metaphase catenation, cells were
treated with siSgo1 for 24 h, followed by 1-h treatment with nocodazole to collapse
the mitotic spindle, to aid spreading. Cells were collected by shaking off the mitotic
cells and resuspended in a hypotonic solution of 75 mM KCl and incubated at
37 C for 30 min to expand the cell. Cells were then resuspended in 3:1 metha-
nol:acetic acid and fixed overnight at  20 C. Cells were then spread onto clear
slides by dropping from 1 m height. For assays where topoIIa was reintroduced,
recombinant topo IIa (1 U ml 1, TopoGen) was incubated in the hypotonic step
where the cell membrane becomes hyperpermeable. The hypotonic buffer used
here contained 5 mM Tris-Cl, pH 8.0, 75 mM KCl, 10 mM MgCl2, 0.5 mM ATP,
0.5 mM dithiothreitol. We confirmed by video-microscopy that there was no
significant difference between the time that all samples had been arrested in mitosis
at the start of the assay.
Statistical tests. In all cases where P-values are given an unpaired t-test was used.
In the cases where the data includes more than two conditions, a one-way analysis
of variance was used. Prism software (Graphpad) was used for all calculations. The
level of statistical significance is represented as follows: n.s.¼P40.05, *¼ Pr0.05,
**¼ Pr0.01, ***¼ Pr0.001 and ****¼ Pr0.0001.
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